# India's Sun Pharmaceutical Industries will buy Organon & Co in an all-cash ‌deal.

*biotech · news · 2026-04-27 · Business Standard*

## Key points

- Sun Pharmaceutical Industries will acquire Organon & Co in an all-cash deal valued at $11.75 billion.
- Sun Pharma will pay $14.00 per Organon share in cash according to the agreement.
- The acquisition grants Sun Pharma full ownership of Organon, spun off from Merck in 2021.
- Organon specializes in women's health, biosimilars, and established medicines.

**Companies:** Sun Pharmaceutical Industries, Organon & Co
**Countries:** India, United States

[Read the full story on Business Standard](https://www.business-standard.com/companies/news/sun-pharma-to-acquire-us-drugmaker-organon-in-11-75-billion-all-cash-deal-126042700071_1.html)

---

Canonical: https://newsio.io/n/d3bd958c-cbd4-4c62-bd14-108b26cc0b43/indias-sun-pharmaceutical-industries-will-buy-organon-co-in-an-all-cash-deal-the
Summarized by Newsio from Business Standard. https://newsio.io/how-it-works